Beta Bionics, Inc. (BBNX)
17.27
-0.38
(-2.15%)
USD |
NASDAQ |
Jan 13, 16:00
17.06
-0.21
(-1.22%)
After-Hours: 20:00
Beta Bionics EPS Diluted (Quarterly): -0.3256 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.21M |
| Revenue (Quarterly) | 27.25M |
| Total Expenses (Quarterly) | 41.46M |
| Enterprise Value | 539.30M |
| Gross Profit Margin (Quarterly) | 55.48% |
| Profit Margin (Quarterly) | -52.14% |
| Earnings Yield | -10.38% |
| Normalized Earnings Yield | -8.652 |